Markets
Nia Warfield, Luke Kawa

US stocks end July on a soft note


The S&P 500 opened 1% higher after last night’s blockbuster earnings from Microsoft and Meta lit a fire under the entire AI complex. Unfortunately, the day only got worse from there.

US stocks slid throughout the session, ending near their lows. The S&P 500 gave back 0.4%, the Nasdaq 100 fell 0.5%, and the Russell 2000 underperformed with a 0.9% decline.

This ends July as the S&P 500’s first month without a daily gain or loss of at least 1% since two years ago, in July 2023.

Healthcare was far and away the worst-performing S&P 500 sector ETF, with drugmakers including Eli Lilly, Pfizer, and Novo Nordisk falling after President Trump sent a letter to 17 pharma CEOs demanding they cut US drug prices within 60 days.

On the positive side, eBay soared 18%, touching an all-time high a day after the online marketplace posted strong Q2 results and analysts issued a pair of price target hikes. Declines were led by Align Technology, which sank a massive 36% after the Invisalign maker missed both top- and bottom-line Q2 estimates.

Elsewhere…

Meta shares jumped another 11% after the social media and AI behemoth topped Q2 estimates Wednesday. Ad revenue — which makes up the majority of its total — leapt 21%.

Microsoft shares rose another 4% after the company’s blowout fiscal Q4 earnings, pushing its valuation above $4 trillion for the first time.

Norwegian Cruise Line sailed up 9% after the cruise operator reaffirmed full-year guidance despite so-so Q2 results, citing a rebound in bookings.

Roblox jumped 10% after the gaming platform beat estimates, with total bookings climbing to $1.4 billion.

CVS Health climbed as much as 6% before closing flat after the pharmacy retailer topped Q2 estimates and raised its full-year outlook.

SoFi Technologies bounced up 3%, marking its third straight day of big moves after Deutsche Bank and Mizuho hiked their price targets on the stock.

Comcast shares closed up 2.2% after the media and cable giant delivered a strong Q2 earnings beat, fueled in part by the debut of its Epic Universe park and hit Peacock shows.

AB InBev fell 13% as the world’s largest brewer continued to report declining sales volume with each passing quarter.

Cigna shares dropped 10%, despite the healthcare insurer beating Q2 estimates and showing solid cost control during the quarter.

More Markets

See all Markets
markets
Luke Kawa

Broadcom jumps after locking down Google as a customer for future generations of TPUs

Shares of Broadcom rose more than 3% in postmarket trading on Monday after its most important customer doubled down on the custom chip specialist’s ability to produce its most valuable commodity.

In a filing, Broadcom said that it entered into a long-term agreement with Google to supply future generations of TPUs (custom AI accelerator chips) as well as a supply assurance agreement for networking and other equipment “through up to 2031.”

Bernstein analyst Stacy Rasgon indicated that Broadcom’s investor relations team told him that Google’s long-term agreement “has revenue commitments that go along with it through the timeline.”

Gemini 3 launched to rave reviews in November. The model was trained on TPUs co-developed by Broadcom and Google.

The same Monday filing showed that Broadcom, Google, and Anthropic expanded a partnership that will see the Claude developer access 3.5 gigawatts of AI compute capacity beginning in 2027, powered by the TPUs co-designed by the custom chip specialist and the search giant.

Bernstein’s Rasgon added that Broadcom’s team suggested these 3.5 gigawatts are “only part of a larger partnership over time.” He thinks Broadcom’s fiscal year 2027 guidance for AI revenues of $100 billion “is looking increasingly light” thanks to this news.

For what it’s worth, the enhanced pact with Anthropic hinges upon the firm’s ability to afford AI compute. But based on the insane trajectory of its run-rate revenue that may not be a big hurdle to clear.

“Broadcom’s expanded agreements with Google and Anthropic add rare multi-year visibility, reinforcing a $40-$50 billion AI revenue opportunity tied to Anthropic’s 3.5 gigawatt deployment starting in 2027, while building on the previously disclosed 1GW ($10 billion) starting in 2H,” wrote Bloomberg Intelligence analysts Kunjan Sobhani and Oscar Hernandez Tejada.

Luke Kawa
8h
Anthropic boasts revenue run rate of $30 billion as the Claude developer expands its partnership with Google and Broadcom

Anthropic’s revenue run rate is higher than the trailing 12-month revenues of all but 129 S&P 500 companies.

Anthropic Co-founder and CEO Dario Amodei
markets
Luke Kawa

Health insurers surge after Medicare agrees to pay 2.48% more in 2027, a bigger-than-expected boost

Health insurance stocks are surging after the Centers for Medicare & Medicaid Services said it plans to boost Medicare Advantage and Part D payments by 2.48% in calendar year 2027.

The likes of CVS, Humana, UnitedHealth, Molina Healthcare, Oscar Health, and Elevance Health are gaining in postmarket trading.

Wall Street analysts had anticipated that rates for 2027 would go up between roughly 1% and 1.5%.

These stocks had gotten crushed in late January when the Trump administration proposed relatively flat federal payment rates.

Insurance companies that provide government-sponsored plans, like Medicare Advantage, faced headwinds from higher-than-expected costs in 2025.

Luke Kawa, Tasha Matsumoto
12h
Stocks maintain gains after whipsawing as traders digest war updates

Stocks rose for the fourth consecutive session as traders vacillated between hopes for a ceasefire and fears of an escalation.

Bull kicks
markets
Matt Phillips

Iran war winners Dow, LyondellBasell downgraded by Bank of America

Dow, Inc. and LyondellBasell — two petrochemicals stocks that surged as markets priced in shortages due to the closure of the Strait of Hormuz — should decline as investors focus on the long-term outlook for normalized petrochemical prices once the war resolves, Bank of America analysts wrote in a note downgrading the two stocks Monday.

BofA moved its rating on the shares from “neutral” to “underperform,” writing:

“Over time, as chemical markets normalize, we expect 1) investor focus to shiſt back to ‘normal’ or ‘sustainable’ earnings profiles and 2) the conflict to resolve without material asset rationalization, both of which likely bias shares lower over the next twelve months.”

Analysts also lowered their stance on another petrochemicals and building materials stock, Westlake, to “neutral” from “buy.”

While cutting those ratings, BofA actually raised its more near-term price targets for the shares. It upped LyondellBasell to $68 from $55, and Dow to $35 from $31.

But those price targets still imply declines of more than 10% compared to where both shares were trading late Monday morning. Both stocks are up roughly 30% since the start of the Iran war.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.
©2026 Sherwood Media, LLC